STCOSD
LGND icon

Sageworth Trust Company of South Dakota’s Ligand Pharmaceuticals LGND Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10
Closed -$1K – 463
2022
Q2 		$1K Hold
10
– – ﹤0.01% 492
2022
Q1 		$1K Sell
10
-65
-87% -$4.72K ﹤0.01% 533
2021
Q4 		$7K Buy
+75
New +$6.93K 0.01% 459

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Sageworth Trust Company of South Dakota's LGND Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Ligand Pharmaceuticals (LGND) in Q3 2022, closing a stake of 10 shares — an estimated $1K sold.

Sageworth Trust Company of South Dakota first reported a position in LGND in Q4 2021 and held it in 3 quarters. The position peaked at $7K in Q4 2021. 205 funds tracked by Wall St. Rank hold LGND as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Ligand Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 10 Ligand Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Sageworth Trust Company of South Dakota first reported a position in Ligand Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Ligand Pharmaceuticals position peaked at $7K in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.